Development of a Novel EGFR-Targeting Antibody-Drug Conjugate for Pancreatic Cancer Therapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Works matching IS 17762596 AND DT 2019 AND VI 14 AND IP 1
Results: 12
1
2
Phase I Study of the Focal Adhesion Kinase Inhibitor BI 853520 in Japanese and Taiwanese Patients with Advanced or Metastatic Solid Tumors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
3
Cabozantinib: A Review in Advanced Hepatocellular Carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
4
Outcomes for Metastatic Colorectal Cancer Based on Microsatellite Instability: Results from the South Australian Metastatic Colorectal Cancer Registry.
- Published in:
- 2019
- By:
- Publication type:
- journal article
5
BI 853520, a FAK-Simile of Prior FAK Inhibitors?
- Published in:
- 2019
- By:
- Publication type:
- Letter
6
Correction to: Fulvestrant-Based Combination Therapy for Second-Line Treatment of Hormone Receptor-Positive Advanced Breast Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
7
Phase 2 Multicenter Single-Arm Study of Second-Line Axitinib in Favorable Risk Patients with Metastatic Renal Cell Carcinoma: FavorAx.
- Published in:
- 2019
- By:
- Publication type:
- journal article
8
Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib.
- Published in:
- 2019
- By:
- Publication type:
- journal article
9
The Challenge of Managing Bladder Cancer and Upper Tract Urothelial Carcinoma: A Review with Treatment Recommendations from the Spanish Oncology Genitourinary Group (SOGUG).
- Published in:
- 2019
- By:
- Publication type:
- journal article
10
Randomized, Open-Label, Crossover Studies Evaluating the Effect of Food and Liquid Formulation on the Pharmacokinetics of the Novel Focal Adhesion Kinase (FAK) Inhibitor BI 853520.
- Published in:
- 2019
- By:
- Publication type:
- journal article
11
Phase I Study of BI 853520, an Inhibitor of Focal Adhesion Kinase, in Patients with Advanced or Metastatic Nonhematologic Malignancies.
- Published in:
- 2019
- By:
- Publication type:
- journal article
12
Fulvestrant-Based Combination Therapy for Second-Line Treatment of Hormone Receptor-Positive Advanced Breast Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article